Kuai Ma
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The immune effects of mesenchymal stem cell-based therapy in kidney diseases.
Journal: Life medicine
Published: October 21, 2025
5-aminolaevulinic acid combined with sodium ferrous citrate ameliorated collagen-induced arthritis via anti-inflammatory effects and fibroblast-like synoviocytes-driven B cell immunomodulation.
Journal: International immunopharmacology
Published: June 06, 2025
Correction: Occurrence and role of Tph cells in various renal diseases.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 13, 2024
Immune imbalance in Lupus Nephritis: The intersection of T-Cell and ferroptosis.
Journal: Frontiers in immunology
Published: October 31, 2024
5-aminolaevulinic acid with sodium ferrous citrate alleviated kidney injury and fibrosis in a unilateral ureteral obstruction model.
Journal: International immunopharmacology
Published: September 29, 2024
The immune regulatory role of lymphangiogenesis in kidney disease.
Journal: Journal of translational medicine
Published: August 20, 2024
Occurrence and role of Tph cells in various renal diseases.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 18, 2024
The effects of apoptosis inhibitor of macrophage in kidney diseases.
Journal: European journal of medical research
Published: August 27, 2023
Research Progress of Pyroptosis in Renal Diseases.
Journal: Current medicinal chemistry
Published: March 30, 2023
Coral calcium carried hydrogen ameliorates the severity of non-alcoholic steatohepatitis induced by a choline deficient high carbohydrate fat-free diet in elderly rats.
Journal: Scientific reports
Published: March 27, 2023
Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation.
Journal: Oxidative medicine and cellular longevity
Published: August 17, 2022
Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells.
Journal: Science advances
Published: August 03, 2022
Last Updated: 09/26/2026